Krishna Thavarajah

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Validity of two new patient‐reported outcome measures in systemic sclerosis: Patient‐reported outcomes measurement information system 29‐item health profile and functional assessment of chronic illness therapy–dyspnea short form

Monique Hinchcliff, Jennifer L. Beaumont, Krishna Thavarajah et al. · Arthritis Care & Research · 2011 · 136 citations · Full text

Pharmacy, Diagnostic Sciences, Clinical Classification Systems +16

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

Toby M. Maher, Paul Ford, Kevin M. Brown et al. · JAMA · 2023 · 127 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Predischarge Bundle for Patients With Acute Exacerbations of COPD to Reduce Readmissions and ED Visits

Jeffrey Jennings, Krishna Thavarajah, Michael Mendez et al. · CHEST Journal · 2014 · 89 citations

Medicine, Clinical Sciences, Internal Medicine +11

Longitudinal Evaluation of PROMIS-29 and FACIT-Dyspnea Short Forms in Systemic Sclerosis

Monique Hinchcliff, Jennifer L. Beaumont, Mary Carns et al. · The Journal of Rheumatology · 2014 · 56 citations · Full text

Pharmacy, Chronic Disease Control, Health Assessment +16